Jane Street’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$666K Buy
9,100
+3,200
+54% +$220K ﹤0.01% 7390
2026
Q1
$377K Sell
5,900
-1,400
-19% -$97.2K ﹤0.01% 8702
2025
Q4
$580K Buy
+7,300
New +$617K ﹤0.01% 7352
2025
Q1
Sell
-3,600
Closed -$228K 9995
2024
Q4
$228K Buy
+3,600
New +$208K ﹤0.01% 8186
2024
Q2
Sell
-72,200
Closed -$4.5M 9772
2024
Q1
$4.5M Buy
72,200
+67,700
+1,504% +$4.39M ﹤0.01% 2780
2023
Q4
$260K Buy
+4,500
New +$230K ﹤0.01% 7836
2021
Q4
Sell
-840
Closed -$102K 10437
2021
Q3
$102K Buy
840
+377
+81% +$51.5K ﹤0.01% 9283
2021
Q2
$90K Buy
+463
New +$152K ﹤0.01% 9309

Other funds holding IRON

Jane Street's IRON Position: Q2 2026 in Review

Jane Street opened a new position in Disc Medicine (IRON) in Q2 2026: 16,011 shares worth $1.17M. The stake represents ﹤0.01% of the portfolio and ranks #6196 among its holdings. This is a return to the name: Jane Street previously reported a position in IRON as recently as Q3 2025.

Jane Street first reported a position in IRON in Q4 2021 and has held it in 10 quarters since. The position peaked at $2.54M in Q1 2024. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Jane Street held 16,011 shares of Disc Medicine worth $1.17M as of Q2 2026.
  • Disc Medicine was a new Jane Street position in Q2 2026.
  • Disc Medicine made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #6196 holding.
  • Jane Street first reported a position in Disc Medicine in Q4 2021 and has held it in 10 quarters since.
  • Jane Street's Disc Medicine position peaked at $2.54M in Q1 2024.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.